In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Jan 17

PMID 31940973

Citations 8

Authors

Wei Peng

Henriette S de Bruijn

Timo L M Ten Hagen

Kristian Berg

Jan L N Roodenburg

Go M van Dam

Max J H Witjes

Dominic J Robinson

Affiliations

Soon will be listed here.

Abstract

Targeted photodynamic therapy (PDT) has the potential to improve the therapeutic effect of PDT due to significantly better tumor responses and less normal tissue damage. Here we investigated if the efficacy of epidermal growth factor receptor (EGFR) targeted PDT using cetuximab-IRDye700DX is fluence rate dependent. Cell survival after treatment with different fluence rates was investigated in three cell lines. Singlet oxygen formation was investigated using the singlet oxygen quencher sodium azide and singlet oxygen sensor green (SOSG). The long-term response (to 90 days) of solid OSC-19-luc2-cGFP tumors in mice was determined after illumination with 20, 50, or 150 mW·cm. Reflectance and fluorescence spectroscopy were used to monitor therapy. Singlet oxygen was formed during illumination as shown by the increase in SOSG fluorescence and the decreased response in the presence of sodium azide. Significantly more cell death and more cures were observed after reducing the fluence rate from 150 mW·cm to 20 mW·cm both in-vitro and in-vivo. Photobleaching of IRDye700DX increased with lower fluence rates and correlated with efficacy. The response in EGFR targeted PDT is strongly dependent on fluence rate used. The effectiveness of targeted PDT is, like PDT, dependent on the generation of singlet oxygen and thus the availability of intracellular oxygen.

Citing Articles

Increasing the Dye Payload of Cetuximab-IRDye800CW Enables Photodynamic Therapy.

Nguyen A, Bhandari C, Keown M, Malkoochi A, Quaye M, Mahmoud D Mol Pharm. 2024; 21(7):3296-3309.

PMID: 38861020 PMC: 11216862. DOI: 10.1021/acs.molpharmaceut.4c00046.

In Vitro Exploration of Dark Cytotoxicity of Anthocyanin-Curcumin Combination, A Herbal Photosensitizer.

M D, T N U, Eswaramoorthy R Cureus. 2024; 16(3):e56714.

PMID: 38646222 PMC: 11032689. DOI: 10.7759/cureus.56714.

Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.

Dorst D, Smeets E, Klein C, Frielink C, Geijs D, Trajkovic-Arsic M Mol Pharm. 2023; 20(8):4319-4330.

PMID: 37485886 PMC: 10410663. DOI: 10.1021/acs.molpharmaceut.3c00453.

Nanobody-targeted photodynamic therapy for the treatment of feline oral carcinoma: a step towards translation to the veterinary clinic.

Hernandez I, Grinwis G, Di Maggio A, Van Bergen en Henegouwen P, Hennink W, Teske E Nanophotonics. 2022; 10(12):3075-3087.

PMID: 36405501 PMC: 9646246. DOI: 10.1515/nanoph-2021-0195.

EGFR-Targeted Photodynamic Therapy.

Ulfo L, Costantini P, Di Giosia M, Danielli A, Calvaresi M Pharmaceutics. 2022; 14(2).

PMID: 35213974 PMC: 8879084. DOI: 10.3390/pharmaceutics14020241.

References

Souza A, Marra K, Gunn J, Samkoe K, Kanick S, Davis S . Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer. Br J Cancer. 2016; 115(7):805-13. PMC: 5046214. DOI: 10.1038/bjc.2016.267. View

Grandis J, Tweardy D . Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993; 53(15):3579-84. View

Middelburg T, Van Zaane F, de Bruijn H, van der Ploeg-van den Heuvel A, Sterenborg H, Neumann H . Fractionated illumination at low fluence rate photodynamic therapy in mice. Photochem Photobiol. 2010; 86(5):1140-6. DOI: 10.1111/j.1751-1097.2010.00760.x. View

van Leeuwen-van Zaane F, Gamm U, van Driel P, Snoeks T, de Bruijn H, van der Ploeg-van den Heuvel A . Intrinsic photosensitizer fluorescence measured using multi-diameter single-fiber spectroscopy in vivo. J Biomed Opt. 2014; 19(1):15010. DOI: 10.1117/1.JBO.19.1.015010. View

van der Veen N, van Leengoed H, Star W . In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer. 1994; 70(5):867-72. PMC: 2033562. DOI: 10.1038/bjc.1994.412. View

Schouwink H, Oppelaar H, Ruevekamp M, van der Valk M, Hart G, Rijken P . Oxygen depletion during and after mTHPC-mediated photodynamic therapy in RIF1 and H-MESO1 tumors. Radiat Res. 2003; 159(2):190-8. DOI: 10.1667/0033-7587(2003)159[0190:oddaam]2.0.co;2. View

Coutier S, Bezdetnaya L, Foster T, Guillemin F . Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res. 2002; 158(3):339-45. DOI: 10.1667/0033-7587(2002)158[0339:eoifro]2.0.co;2. View

Kanick S, Sterenborg H, Amelink A . Empirical model of the photon path length for a single fiber reflectance spectroscopy device. Opt Express. 2009; 17(2):860-71. DOI: 10.1364/oe.17.000860. View

Weston M, Patterson M . Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival. Photochem Photobiol. 2011; 87(5):1129-37. DOI: 10.1111/j.1751-1097.2011.00942.x. View

10.

Moan J, Sommer S . Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 1985; 45(4):1608-10. View

11.

Berg K, Madslien K, Bommer J, OFTEBRO R, Winkelman J, Moan J . Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation. Photochem Photobiol. 1991; 53(2):203-10. DOI: 10.1111/j.1751-1097.1991.tb03924.x. View

12.

Robinson D, de Bruijn H, Star W, Sterenborg H . Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem Photobiol. 2003; 77(3):319-23. DOI: 10.1562/0031-8655(2003)077<0319:DATOTF>2.0.CO;2. View

13.

Foster T, Murant R, Bryant R, Knox R, Gibson S, HILF R . Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res. 1991; 126(3):296-303. DOI: 10.2307/3577919. View

14.

Mew D, Wat C, Towers G, LEVY J . Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol. 1983; 130(3):1473-7. View

15.

Robinson D, de Bruijn H, van der Veen N, Stringer M, Brown S, Star W . Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998; 67(1):140-9. View

16.

Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I . Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Mol Oncol. 2014; 8(3):620-32. PMC: 4004687. DOI: 10.1016/j.molonc.2014.01.006. View

17.

van Straten D, Mashayekhi V, de Bruijn H, Oliveira S, Robinson D . Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel). 2017; 9(2). PMC: 5332942. DOI: 10.3390/cancers9020019. View

18.

Henderson B, Gollnick S, Snyder J, Busch T, Kousis P, Cheney R . Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res. 2004; 64(6):2120-6. DOI: 10.1158/0008-5472.can-03-3513. View

19.

Prasad A, Sedlarova M, Pospisil P . Singlet oxygen imaging using fluorescent probe Singlet Oxygen Sensor Green in photosynthetic organisms. Sci Rep. 2018; 8(1):13685. PMC: 6135792. DOI: 10.1038/s41598-018-31638-5. View

20.

Stegehuis P, Boogerd L, Inderson A, Veenendaal R, van Gerven P, Bonsing B . Toward optical guidance during endoscopic ultrasound-guided fine needle aspirations of pancreatic masses using single fiber reflectance spectroscopy: a feasibility study. J Biomed Opt. 2017; 22(2):24001. DOI: 10.1117/1.JBO.22.2.024001. View